Table of Contents

company-logo

GeneOne Life Science, Inc., a biopharmaceutical company, engages in the development and contract manufacturing of gene-based-biomedicines. Its products comprise GLS-1027, which is in Phase I clinical trial for treatment of nephropathy and inflammatory diseases; GLS-1200 that is in Phase II clinical trial to treat Rhinosinusitis; GLS-1027 and GLS-1200, which is Phase II clinical trial for treatment of COVID-19. The company also develops GLS-3000 and GLS-5310 for the treatment of SARS-CoV-2; GLS-5100 to treat VZV-Shingles; and GLS-5140 for the treatment of SFTS. In addition, it is developing GLS-5300, which is in Phase II clinical trial for MERS; GLS-5700 that is in Phase I clinical trial for Zika; and GLS-6150, which is in Phase I clinical trial for treatment of hepatitis C, as well as GLS-6100 that is in pre-clinical stage for hepatitis C. Further, the company, through its subsidiary, VGXI, Inc., engages in the cGMP production of nucleic acid-based products, including DNA plasmids and mRNA. The company was formerly known as VGX International Inc. and changed its name to GeneOne Life Science, Inc. in April 2014. GeneOne Life Science, Inc. was founded in 1976 and is headquartered in Seoul, South Korea.

GeneOne Life Science Dividend Announcement

• GeneOne Life Science does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on GeneOne Life Science dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

GeneOne Life Science Dividend History

GeneOne Life Science Dividend Yield

GeneOne Life Science current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing GeneOne Life Science stock? Use our calculator to estimate your expected dividend yield:

GeneOne Life Science Financial Ratios

P/E ratio-2.40
PEG ratio0.01
P/B ratio1.98
ROE-69.43%
Payout ratio0.00%
Current ratio0.98
Quick ratio0.98
Cash Ratio0.00

GeneOne Life Science Dividend FAQ

Does GeneOne Life Science stock pay dividends?
GeneOne Life Science does not currently pay dividends to its shareholders.
Has GeneOne Life Science ever paid a dividend?
No, GeneOne Life Science has no a history of paying dividends to its shareholders. GeneOne Life Science is not known for its dividend payments.
Why doesn't GeneOne Life Science pay dividends?
There are several potential reasons why GeneOne Life Science would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will GeneOne Life Science ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While GeneOne Life Science has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is GeneOne Life Science a dividend aristocrat?
GeneOne Life Science is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is GeneOne Life Science a dividend king?
GeneOne Life Science is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is GeneOne Life Science a dividend stock?
No, GeneOne Life Science is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy GeneOne Life Science stocks?
To buy GeneOne Life Science you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy GeneOne Life Science stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.